(Q44466407)

3 December 2017

title

Effect of levetiracetam in refractory childhood epilepsy syndromes (English)

1 reference

3 December 2017

1 reference

Lagae L

1

1 reference

3 December 2017

Buyse G

series ordinal

2

1 reference

3 December 2017

Deconinck A

series ordinal

3

1 reference

3 December 2017

Ceulemans B

series ordinal

4

1 reference

3 December 2017

publication date

1 January 2003

1 reference

European Journal of Paediatric Neurology

3 December 2017

published in

1 reference

3 December 2017

volume

7

1 reference

3 December 2017

issue

3

1 reference

3 December 2017

page(s)

123-128

1 reference

Pharmacokinetics of levetiracetam

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2803%2900041-2

7 January 2021

Pharmacokinetic study of levetiracetam in children

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2803%2900041-2

7 January 2021

Levetiracetam does not modulate neuronal voltage-gated Na+ and T-type Ca2+ currents

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2803%2900041-2

7 January 2021

Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures. European Levetiracetam Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2803%2900041-2

7 January 2021

Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2803%2900041-2

7 January 2021

Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. European Levetiracetam Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2803%2900041-2

7 January 2021

Use of levetiracetam in special populations

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2803%2900041-2

7 January 2021

Efficacy and safety of levetiracetam in children with partial seizures: an open-label trial

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2803%2900041-2

7 January 2021

Levetiracetam in refractory pediatric epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2803%2900041-2

7 January 2021

Early identification of refractory epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2803%2900041-2

7 January 2021

Levetiracetam psychosis in children with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2803%2900041-2

7 January 2021

10.1016/S1090-3798(03)00041-2

Identifiers

DOI

1 reference

3 December 2017

1 reference